MedTrace Logo

Colorectal Omics and OfCS Proteoglycans

NCT06287671 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-12-30

No results posted yet for this study

Summary

This observational study aims to test proteomics, metabolomics and proteoglycans as predictors of postoperative complications after colorectal surgery and as biomarkers of colorectal cancer.

The main questions to answer are:

* can these biomarkers predict anastomotic leakages
* can these biomarkers predict recurrence after colorectal cancer
* can these biomarkers be used as diagnostic tests for colorectal cancer
* can these biomarkers be identified in the tumor

Participants will undergo elective colorectal resection or stoma closure.

Conditions

  • Colorectal Cancer
  • Diverticulitis, Colonic
  • Inflammatory Bowel Diseases
  • Stoma Colostomy

Interventions

PROCEDURE

Colorectal resection or stoma closure

Elective open or minimally invasive resection for colorectal cancer, IBD or other benign colorectal disorder, or stoma closure

Sponsors & Collaborators

  • Viborg Regional Hospital

    collaborator OTHER

  • Claus Anders Bertelsen, PhD, MD

    lead OTHER

Principal Investigators

  • Claus A Bertelsen, PhD · Department of Surgery, Copenhagen University Hospital - North Zealand

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-08
Primary Completion
2028-12-31
Completion
2032-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06287671 on ClinicalTrials.gov